Paclitaxel/Cyclophosphamide and High-Dose Melphalan/Etoposide Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IIIB Inflammatory Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00019162 Information provided by National Cancer Institute (NCI)

First Received: July 11, 2001 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)